Casdin Capital’s LianBio American Depositary Shares LIAN Stock Holding History

Casdin Capital’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-206,415	Closed	-$923K	–	41
2023 Q4	$923K	Hold	206,415	–	–	0.09%	36
2023 Q3	$308K	Hold	206,415	–	–	0.03%	39
2023 Q2	$471K	Hold	206,415	–	–	0.04%	39
2023 Q1	$403K	Hold	206,415	–	–	0.03%	40
2022 Q4	$339K	Hold	206,415	–	–	0.03%	45
2022 Q3	$411K	Hold	206,415	–	–	0.03%	37
2022 Q2	$446K	Hold	206,415	–	–	0.04%	40
2022 Q1	$766K	Hold	206,415	–	–	0.03%	47
2021 Q4	$1.27M	Buy	+206,415	New	+$2.36M	0.04%	52

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Casdin Capital's LIAN Position: Q1 2024 in Review

Casdin Capital sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 206,415 shares — an estimated $923K sold.

Casdin Capital first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $1.27M in Q4 2021. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Casdin Capital reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Casdin Capital sold 206,415 LianBio American Depositary Shares shares in Q1 2024, an estimated $923K.
Casdin Capital first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
Casdin Capital's LianBio American Depositary Shares position peaked at $1.27M in Q4 2021.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Casdin Capital's 13F filing for Q1 2024, filed 15 May 2024.